Abstract:Cellular senescence is implicated in ageing and associated with a broad spectrum of age-related diseases. Importantly, a cell can initiate the senescence program irrespective of the organism's age. Various stress signals, including those defined as ageing hallmarks and alterations leading to cancer development, oncogene activation, or loss of cancer-suppressive functions, can trigger cellular senescence. The primary outcome of these alterations is the activation of nuclear factor (NF)-κB, thereby inducing the senescence-associated secretory phenotype (SASP). Proinflammatory cytokines and chemokines, components of this phenotype, contribute to chronic systemic sterile inflammation, commonly referred to as inflamm-ageing. This inflammation is linked to age-related diseases (ARDs), frailty, and increased mortality in older individuals. Additionally, senescent cells (SCs) accumulate in multiple tissues with age and are believed to underlie the organism functional decline, as demonstrated by models. An escalating effort has been dedicated to identify senotherapeutics that selectively target SCs by inducing apoptosis; these drugs are termed senolytics. Concurrently, small molecules that suppress senescent phenotypes without causing cell death are known as senomorphics. Both natural and synthetic senotherapeutics, along with immunotherapies employing immune cell-mediated clearance of SCs, currently represent the most promising strategies to combat ageing and ARDs. Indeed, it is fascinating to observe that information regarding the immune reaction to SCs indicates that regulation by specific lymphocyte subsets, elevated in the oldest centenarians, plays a role in attaining extreme longevity. Regardless, the application of methods already utilized in cancer treatment, such as CAR cells and monoclonal antibodies, broadens the spectrum of potential approaches to be utilized.

When aging gets on the way of disposal: Senescent cell suppression of efferocytosis

Macrophage Senescence in Health and Diseases

Similarities and interplay between senescent cells and macrophages

The role of senescent T cells in immunopathology

Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies

Senescent cells: SASPected drivers of age-related pathologies

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging

Phagocyte dysfunction, tissue aging and degeneration

Perspectives on the dynamic implications of cellular senescence and immunosenescence on macrophage aging biology

Targeting cellular senescence in metabolic disease

Role of immune cells in the removal of deleterious senescent cells

Senescent Cells in Cancer: Wanted or Unwanted Citizens

Exploring the emerging bidirectional association between inflamm‐aging and cellular senescence in organismal aging and disease

COVID-19 and cellular senescence

Cellular Senescence and Senescent Cell*

Immunosenescence and macrophages: from basics to therapeutics

Senescent Macrophages Release Inflammatory Cytokines and RNA-Loaded Extracellular Vesicles to Circumvent Fibroblast Senescence

Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues

Cellular senescence: Molecular mechanisms and pathogenicity

Impaired immune surveillance accelerates accumulation of senescent cells and aging